Leerink Partners Biopharma Private Company Connect Format: 1x1 Investor Meetings Date/Time: Tuesday, October 22 and Wednesday, October 23 Location: Virtual ...

Viking Therapeutics VKTX has outperformed the market over the past 5 years by 41.66% on an annualized basis producing an ...

Viking Therapeutics (NASDAQ: VKTX) has captured the attention of investors, with its stock price skyrocketing over 400% in ...

We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, we will look at where Viking ...

Analyst Justin Zelin from BTIG reiterated a Buy rating on Jasper Therapeutics (JSPR – Research Report) and keeping the price target at ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...

I'm bullish on Viking Therapeutics' weight-loss drug, but warn of risks and competition ahead. Click here to read my most ...

Viking Therapeutics, Inc.'s stock surged 1,500% on the promising obesity drug VK-2735, with Phase 3 trials and potential for ...

Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Let the speculation begin. On the September 23 episode of WWE RAW, a brief teaser aired. A flaming circle appeared on screen, ...

Several launches in 2027 (Amgen, Altimmune), 2028 (Pfizer, Roche, Viking, and Structure), and 2029 (Roche, Viking, ...